Provided by Tiger Trade Technology Pte. Ltd.

CANSINOBIO

34.980
-0.220-0.63%
Volume:625.20K
Turnover:21.78M
Market Cap:8.64B
PE:318.00
High:35.620
Open:35.300
Low:34.240
Close:35.200
52wk High:56.550
52wk Low:28.650
Shares:247.04M
HK Float Shares:132.67M
Volume Ratio:0.72
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.110
ROE:0.57%
ROA:-0.72%
PB:1.52
PE(LYR):318.00
PS:7.06

Loading ...

CANSINOBIO Schedules 28 April Board Meeting to Approve Q1 2026 Results

Bulletin Express
·
Yesterday

CanSino Biologics Infant Combination Vaccine Approved in China

MT Newswires Live
·
Apr 13

Hong Kong Grants First Stablecoin Issuer Licenses as Iran-US Talks Show Major Rifts

Stock News
·
Apr 13

CANSINOBIO receives NMPA approval for China’s first component-based DTcP vaccine for infants

Bulletin Express
·
Apr 12

CANSINOBIO's Infant DTcP Vaccine Receives NDA Approval from China's NMPA

Stock News
·
Apr 12

Stock Track | CANSINOBIO Soars 9.68% Intraday on Strong Annual Results, Profit Turnaround and Dividend Plan

Stock Track
·
Apr 01

CANSINOBIO Shares Surge Nearly 10% Pre-Midday on Meningococcal Vaccine Revenue Growth and Annual Profit Turnaround

Stock News
·
Apr 01

CANSINOBIO (06185) Reports 2025 Financial Results: Revenue Reaches Approximately 1.059 Billion Yuan, Up 28.43% Year-on-Year

Stock News
·
Mar 31

CANSINOBIO (06185) Sets 30 March 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal

Bulletin Express
·
Mar 17

CanSino Biologics Surges Over 5% Following Malaysian PIC/S GMP Certification for Production Facility

Stock News
·
Mar 06

Stock Track | CanSino Biologics Soars 5.59% in Morning Session on Malaysia GMP Certification

Stock Track
·
Mar 06

CanSino Biologics Receives Malaysia GMP Certificate for Vaccine Facility

MT Newswires Live
·
Mar 06

CANSINOBIO (06185) Obtains PIC/S GMP Certificate for MCV4 and PCV13i

Bulletin Express
·
Mar 05

CANSINOBIO (06185) Secures PIC/S GMP Certification

Stock News
·
Mar 05

CanSino Biologics Inc. (06185) Publishes February 2026 Monthly Return

Bulletin Express
·
Mar 02

CanSino Biologics' Preliminary Figures Show Return to Profit in 2025; Shares Up 6%

MT Newswires Live
·
Feb 27

CanSino Biologics Inc. (6185) Announces 2025 Preliminary Annual Results

Bulletin Express
·
Feb 26

CANSINOBIO (06185) Issues 2025 Performance Report, Returns to Profitability

Stock News
·
Feb 26

CanSino Biologics Inc. (6185) Receives NMPA Approval to Expand Menhycia® Vaccine Age Range

Bulletin Express
·
Feb 24

CANSINOBIO's Meningococcal Vaccine Menhycyte™ Receives Expanded Age Indication Approval

Stock News
·
Feb 24